Bone marrow heterogeneous hyperplasia may refer to myelodysplastic syndromes, routine blood test found simple thrombocytopenia, can not rule out the possibility of myelodysplastic syndromes.
Routine blood test found simple thrombocytopenia, red blood cells do not decrease, white blood cells do not decrease, still can not rule out the myelodysplastic syndrome, because the diagnostic criteria for myelodysplastic syndrome, as long as a series of three lineage reduction can be, that is, there may be a drop in platelets, but white blood cells and red blood cells are normal phenomenon.
However, the more important criteria for myelodysplastic syndromes are pathologic hematopoiesis and 5% to 19% primitive cells in the bone marrow, along with chromosomal abnormalities. Therefore, a definitive diagnosis is still required through specialized tests such as bone marrow aspiration.
Myelodysplastic syndromes are a group of suppressive myeloid clonal disorders originating from hematopoietic stem cells, characterized by ineffective hematopoiesis, refractory anemia, hematopoietic failure, and possible transformation to acute myeloid leukemia.
If myelodysplastic syndrome is suspected, it is necessary to complete other tests as soon as possible and cooperate with the doctor for treatment if necessary.